-+ 0.00%
-+ 0.00%
-+ 0.00%

Vir Biotechnology names Timothy Coughlin to board, taps him as audit committee chair

PUBT·06/10/2026 20:05:22
Listen to the news
Vir Biotechnology names Timothy Coughlin to board, taps him as audit committee chair
  • Vir Biotechnology appointed Timothy Coughlin to its board, effective June 9, 2026.
  • Coughlin will chair the audit committee.
  • He previously served as CFO of Neurocrine Biosciences, helping shift it from clinical-stage to a commercial pharmaceutical company.
  • Earlier roles include vice president of financial services at Catholic Health Initiatives, with prior experience at Ernst & Young.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Vir Biotechnology Inc. published the original content used to generate this news brief via Business Wire (Ref. ID: 202606101605BIZWIRE_USPR_____20260610_BW324261) on June 10, 2026, and is solely responsible for the information contained therein.